Home » Topics » Articles » Insight

Insight
RSS

Venture Capital, PIPE/Reg. S, And Corporate Investments

Feb. 9, 1998

Underwriters' Performance On 1997's IPOs: Full Credit To Lead Underwriter,

Feb. 2, 1998

Underwriters' Performance On 1997's IPOs: Full Credit To Lead Underwriter, Ranked By After-Market Performance

Feb. 2, 1998

H&Q Still Dominates Biotech Stock Offerings

Feb. 2, 1998

1997's Biotechnology Initial Public Offerings

Feb. 2, 1998

Underwriters' Performance On 1997's IPOs: Full Credit To All Underwriters,

Feb. 2, 1998

Big Pharma Mergers Raise Alarms For Biotech Partners

Jan. 26, 1998

By Jennifer Van Brunt

Big Pharma - Biotech Collaborations: Modified And Terminated Agreements: October - December 1997#

Jan. 26, 1998

Manufacturing, Marketing and Distribution Agreements Between Biotechnology And Pharmaceutical Companies: October 1997 - December 1997#

Jan. 26, 1998

Big Pharma Spends Lavishly To Access Biotech Expertise

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...